e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Biomarkers of idiopathic interstitial pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases
V. Tan (SingaporeS, Singapore), S. Tay (SingaporeS, Singapore), F. Teo (SingaporeS, Singapore), P. Quah (SingaporeS, Singapore), L. Teo (SingaporeS, Singapore), C. Ong (SingaporeS, Singapore), J. Seet (SingaporeS, Singapore), T. Lim (SingaporeS, Singapore)
Source:
International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Session:
Biomarkers of idiopathic interstitial pneumonia
Session type:
Thematic Poster
Number:
4693
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Tan (SingaporeS, Singapore), S. Tay (SingaporeS, Singapore), F. Teo (SingaporeS, Singapore), P. Quah (SingaporeS, Singapore), L. Teo (SingaporeS, Singapore), C. Ong (SingaporeS, Singapore), J. Seet (SingaporeS, Singapore), T. Lim (SingaporeS, Singapore). Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases. 4693
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used
Source: International Congress 2017 – Rare diseases
Year: 2017
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases.
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Provident Diagnostic Method for Interstitial Lung Disease: Awake Uniportal Videothoracoscopy
Source: International Congress 2017 – Thoracic surgery
Year: 2017
ATS / ERS: International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias
Source: Guideline 2002
Year: 2002
Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease
Source: Breathe 2014; 10:173-175
Year: 2014
Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021
Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Autoantibodies in Interstitial Lung Diseases
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Effect of Pulmonary Rehabilitation on Functional Exercise Capacity and Hypoxemia in Patients with Interstitial Lung Diseases: a retrospective study
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Hospitalisation pattern in Interstitial Lung Diseases: a claims data study
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Multicenter Registry of Interstitial Lung Diseases in Brazil
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Verification of genetic associations with Scleroderma associated Interstitial Lung Disease
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept